Medical Properties Trust (MPW) Tops Q3 FFO by 1c, Offers FY11 Outlook
Tweet
Share
E-mailGet Alerts MPW Hot Sheet
Price: $5.02 --0%
Financial Fact:
Income (loss) from continuing operations: 70.54M
Today's EPS Names:
CCEL, FEIM, PLG, More
Financial Fact:
Income (loss) from continuing operations: 70.54M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Medical Properties Trust (NYSE: MPW) reported Q3 FFO of $0.18, $0.01 better than the analyst estimate of $0.17. Revenue for the quarter came in at $37.79 million versus the consensus estimate of $39.46 million.
Based solely on the portfolio as of September 30, 2011 and including the Hoboken acquisition and the completion of the Florence hospital currently under construction, the Company estimates that annualized Normalized FFO per share would approximate $0.76 to $0.80 per diluted share. The Company further estimates that its existing portfolio of assets plus approximately $275.0 million of assets expected to be acquired with available liquidity will generate Normalized FFO of between $0.93 and $0.97 per diluted share on an annualized basis once fully invested.
Based solely on the portfolio as of September 30, 2011 and including the Hoboken acquisition and the completion of the Florence hospital currently under construction, the Company estimates that annualized Normalized FFO per share would approximate $0.76 to $0.80 per diluted share. The Company further estimates that its existing portfolio of assets plus approximately $275.0 million of assets expected to be acquired with available liquidity will generate Normalized FFO of between $0.93 and $0.97 per diluted share on an annualized basis once fully invested.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Delta Air Lines (DAL) Tops Q2 EPS by 3c, Beats on Revenue; Offers Guidance
- Wrap Technologies outlines platform shift toward AI-driven public safety
- Ionis Pharmaceuticals (IONS) reaffirms guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
